Clinical Trial Update: Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma [Phase 2]

View source ↗

Summary

This Phase 2 study comparing ARS-1 and albuterol in persistent asthma has completed. The trial evaluates ARS-1 against a standard bronchodilator, albuterol.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ARS-1
• Albuterol (albuterol)

Snippet

Sponsor: ARS Pharmaceuticals, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED